Recombinant respiratory syncytial virus pre-fusion F protein vaccine

Description

In this Product Explainer, Infectious Disease Physician and Microbiologist Prof Paul Griffin explains the role of a recombinant respiratory syncytial virus pre-fusion F protein vaccine for prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).

Additional resources

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ralph Audehm & A/Prof Jeremy Grummet

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

New Prostate Cancer Screening Guidelines – Case-Based Explanation for GP

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism & Mental Health Comorbidities

Dr Rebecca Purvis

Dr Rebecca Purvis

Pharmacogenomics in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland

Date published: 29 October 2024